Multiple Sclerosis Trial, Recruiting NCT04806568 Sponsor: Aristotle University Of Thessaloniki Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT04806568
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Multiple Sclerosis (MS):

  • You are between 18 and 65 years old
  • You have been officially diagnosed with MS using standard medical guidelines (2017 McDonald criteria)
  • Your level of physical disability falls within a specific measured range (confirm with trial site for details on the EDSS score 0–6.5)
  • You have either a relapsing or progressive form of MS
  • Your MS symptoms have been stable for at least one month before the study begins
  • You have been on the same MS medication for at least 6 months

For healthy volunteers (people without MS):

  • You have normal hearing and normal vision (glasses or contact lenses are acceptable)

Who may not be able to join:

For people with MS:

  • People who may be unable or unwilling to follow the study's requirements
  • People who have another condition affecting the brain or nervous system that is similar to MS
  • People who have another active immune system disease (other than MS), or a stable immune condition being treated with immune therapy
  • People who have another significant brain or nervous system condition, or a serious mental health condition that could affect their ability to participate
  • People who are unable or unwilling to have MRI scans and EEG brain activity tests

For healthy volunteers:

  • People who have any diagnosed neurological, mental, developmental, or psychiatric condition
  • People who have not fully recovered from a neurological event such as a stroke or brain injury
  • People whose medications have changed or been unstable in the last 3 months
  • People who are currently taking medications that affect the brain or nervous system (such as antidepressants)
  • People with a serious physical health condition
  • People who are currently taking part in another relevant research study
  • People who are unable or unwilling to have an EEG brain activity test

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Charis Styliadis, PhD, Aristotle University Of Thessaloniki

Phone: 6942618582

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Aristotle University Of Thessaloniki
Registry
ClinicalTrials.gov
Start date
1 December 2020
Est. completion
31 December 2025

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Change in current density strength of the cortical activity as measured via EEG; Change in cortical connectivity as measured via EEG; Changes in the graph theory indexes as measured via EEG

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov